Age Related Macular Degeneration Market By Drug Type (Aflibercept, Ranibizumab, Others) , By Disease Type (Wet Age Related Macular Degeneration (AMD) , Dry Age Related Macular Degeneration (AMD)) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Age Related Macular Degeneration Market
The age related macular degeneration market was valued at $10.0 billion in 2023 and is projected t%li%reach $16.2 billion by 2033, growing at a CAGR of 5% from 2024 t%li%2033.
Age related macular degeneration is a visual impairment in which the central portion of the retina, known as macula, deteriorates. Beginning with slight blurred vision, the disease eventually leads t%li%loss of central eyesight. There are tw%li%categories of the disease: dry (atrophic) and wet (neovascular). Gradual thinning of the macula occurs in dry macular degeneration, whereas wet macular degeneration happens due t%li%abnormal growth of blood vessels under the retina.
Exponential increase in the aging population and rise in prevalence of the disease are the key drivers of the age related macular degeneration market. In addition, advancements in diagnostic techniques are leading t%li%early detection and timely treatment of the disease, thereby augmenting the market development. In recent times, AI and deep learning are revolutionizing the landscape of age related macular degeneration diagnosis and treatment. The technology helps in precise detection of the eye condition and assesses the risk pertaining t%li%the progression of the disease t%li%advanced stages.
However, in case of disease advancement t%li%high stages, treatment procedures exhibit limited t%li%n%li%efficacy, thereby restraining the growth of the age related macular degeneration market. Moreover, the high expense of purchasing medications essential for curing the disease, such as anti-vascular endothelial growth factor injections, constraints several patients from undergoing the treatment. This hampers the development of the market. According t%li%an article published by the UK-based scientific journals publisher—BioMed Central— age related macular degeneration is one of the leading causes of vision loss and by 2040, the disease is anticipated t%li%impact 288 million individuals.
Segment Review
The age related macular degeneration market is segmented int%li%drug type, disease type, distribution channel, and region. On the basis of drug type, the market is divided int%li%aflibercept, ranibizumab, and others. Depending on disease type, it is bifurcated int%li%wet age related macular degeneration (AMD) and dry age related macular degeneration (AMD). As per distribution channel, it is classified int%li%hospital pharmacy, retail pharmacy, and online pharmacy. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of drug type, the aflibercept segment dominates the age related macular degeneration market.
Depending on disease type, the wet age-related macular degeneration (AMD) segment acquires a significant share of the market.
As per distribution channel, the hospital pharmacy segment leads in the market.
Region wise, the market exhibits robust growth in North America.
Competition Analysis
The leading players operating in the global age related macular degeneration market include Regeneron Pharmaceuticals Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Biogen, Bayer AG, Coherus Biosciences Inc, Sanofi, Apellis Pharmaceuticals, Bausch Health Companies Inc., and Ionis Pharmaceuticals, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
By Drug Type
The age related macular degeneration market was valued at $10.0 billion in 2023 and is projected t%li%reach $16.2 billion by 2033, growing at a CAGR of 5% from 2024 t%li%2033.
Age related macular degeneration is a visual impairment in which the central portion of the retina, known as macula, deteriorates. Beginning with slight blurred vision, the disease eventually leads t%li%loss of central eyesight. There are tw%li%categories of the disease: dry (atrophic) and wet (neovascular). Gradual thinning of the macula occurs in dry macular degeneration, whereas wet macular degeneration happens due t%li%abnormal growth of blood vessels under the retina.
Exponential increase in the aging population and rise in prevalence of the disease are the key drivers of the age related macular degeneration market. In addition, advancements in diagnostic techniques are leading t%li%early detection and timely treatment of the disease, thereby augmenting the market development. In recent times, AI and deep learning are revolutionizing the landscape of age related macular degeneration diagnosis and treatment. The technology helps in precise detection of the eye condition and assesses the risk pertaining t%li%the progression of the disease t%li%advanced stages.
However, in case of disease advancement t%li%high stages, treatment procedures exhibit limited t%li%n%li%efficacy, thereby restraining the growth of the age related macular degeneration market. Moreover, the high expense of purchasing medications essential for curing the disease, such as anti-vascular endothelial growth factor injections, constraints several patients from undergoing the treatment. This hampers the development of the market. According t%li%an article published by the UK-based scientific journals publisher—BioMed Central— age related macular degeneration is one of the leading causes of vision loss and by 2040, the disease is anticipated t%li%impact 288 million individuals.
Segment Review
The age related macular degeneration market is segmented int%li%drug type, disease type, distribution channel, and region. On the basis of drug type, the market is divided int%li%aflibercept, ranibizumab, and others. Depending on disease type, it is bifurcated int%li%wet age related macular degeneration (AMD) and dry age related macular degeneration (AMD). As per distribution channel, it is classified int%li%hospital pharmacy, retail pharmacy, and online pharmacy. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of drug type, the aflibercept segment dominates the age related macular degeneration market.
Depending on disease type, the wet age-related macular degeneration (AMD) segment acquires a significant share of the market.
As per distribution channel, the hospital pharmacy segment leads in the market.
Region wise, the market exhibits robust growth in North America.
Competition Analysis
The leading players operating in the global age related macular degeneration market include Regeneron Pharmaceuticals Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Biogen, Bayer AG, Coherus Biosciences Inc, Sanofi, Apellis Pharmaceuticals, Bausch Health Companies Inc., and Ionis Pharmaceuticals, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Expanded list for Company Profiles
- Historic market data
By Drug Type
- Aflibercept
- Ranibizumab
- Others
- Wet Age Related Macular Degeneration (AMD)
- Dry Age Related Macular Degeneration (AMD)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- Regeneron Pharmaceuticals Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- Biogen
- Bayer AG
- Coherus Biosciences Inc
- Sanofi
- Apellis Pharmaceuticals
- Bausch Health Companies Inc.
- Ionis Pharmaceuticals, Inc
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: TANK LINER MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. PVC Liner
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. PE Liner
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: TANK LINER MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Water Tanks
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Oil Tanks
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: TANK LINER MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By Application
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Tank Liner Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By Application
6.2.6. Canada Tank Liner Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By Application
6.2.7. Mexico Tank Liner Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By Application
6.3.4. Market Size and Forecast, By Country
6.3.5. France Tank Liner Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By Application
6.3.6. Germany Tank Liner Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By Application
6.3.7. Italy Tank Liner Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By Application
6.3.8. UK Tank Liner Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By Application
6.3.9. Rest of Europe Tank Liner Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By Application
6.4.4. Market Size and Forecast, By Country
6.4.5. China Tank Liner Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By Application
6.4.6. Japan Tank Liner Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By Application
6.4.7. India Tank Liner Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By Application
6.4.8. South Korea Tank Liner Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By Application
6.4.9. Rest of Asia-Pacific Tank Liner Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By Application
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By Application
6.5.4. Market Size and Forecast, By Country
6.5.5. Latin America Tank Liner Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By Application
6.5.6. Middle East Tank Liner Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By Application
6.5.7. Africa Tank Liner Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Fab-Seal Industrial Liners
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Flexi-Liner
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Fabtech
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Layfield Group
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Rostfrei Steels
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Witt Lining Systems
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Walco
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Freedom Manufacturing
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Fleximake
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Wolftank Adisa
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: TANK LINER MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. PVC Liner
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. PE Liner
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: TANK LINER MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Water Tanks
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Oil Tanks
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: TANK LINER MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By Application
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Tank Liner Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By Application
6.2.6. Canada Tank Liner Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By Application
6.2.7. Mexico Tank Liner Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By Application
6.3.4. Market Size and Forecast, By Country
6.3.5. France Tank Liner Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By Application
6.3.6. Germany Tank Liner Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By Application
6.3.7. Italy Tank Liner Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By Application
6.3.8. UK Tank Liner Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By Application
6.3.9. Rest of Europe Tank Liner Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By Application
6.4.4. Market Size and Forecast, By Country
6.4.5. China Tank Liner Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By Application
6.4.6. Japan Tank Liner Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By Application
6.4.7. India Tank Liner Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By Application
6.4.8. South Korea Tank Liner Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By Application
6.4.9. Rest of Asia-Pacific Tank Liner Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By Application
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By Application
6.5.4. Market Size and Forecast, By Country
6.5.5. Latin America Tank Liner Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By Application
6.5.6. Middle East Tank Liner Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By Application
6.5.7. Africa Tank Liner Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Fab-Seal Industrial Liners
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Flexi-Liner
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Fabtech
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Layfield Group
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Rostfrei Steels
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Witt Lining Systems
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Walco
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Freedom Manufacturing
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Fleximake
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Wolftank Adisa
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
